M. Garau

Switching to darunavir/ritonavir monotherapy vs. triple-therapy on body fat redistribution and bone mass in HIV-infected adults: the Monarch randomized controlled trial

G. Guaraldi, A. Cossarizza, E. Garlassi, 2014, International journal of STD & AIDS.

Randomized Trial to Evaluate Cardiometabolic and Endothelial Function in Patients with Plasma HIV-1 RNA Suppression Switching to Darunavir/Ritonavir with or without Nucleoside Analogues

G. Guaraldi, A. Cossarizza, F. Carli, 2013, HIV clinical trials.

T-Cell Phenotype and Function following a First cART Regimen Containing Either a Protease Inhibitor or a Non-Nucleoside Reverse Transcriptase Inhibitor in HIV-Infected Late Presenters: Results from a Retrospective, ex vivo Study

C. Tincati, G. Marchetti, A. Monforte, 2015, Antiviral therapy.